Trial
NCT00673361
Pilot Trial of "Chemo-Switch" Regimen to Treat Advanced Melanoma
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Duke University
Collaborators
Bayer
Condition
Melanoma
Intervention
Concurrent decrescendo biochemotherapy regimen
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-01-13